Health & Healthcare

Corporate stories about Health & Healthcare across 3BL's network.

Latest in Health & Healthcare

Here's to Lab Week 2022
Quest honors the dedication of all lab professionals providing essential insights that are vital to healthcare decisions.
Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced an agreement with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having a genetic or rare disease.
World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says
Two years into the pandemic that has killed millions and shaken the global economy, the world still lacks a unified effort to detect and fight future outbreaks using genetic tools, said Illumina Inc. Chief Executive Officer Francis deSouza.

Alcohol-related Deaths Increased by 25% in 2020
A new study from the National Institute on Alcohol Abuse and Alcoholism shows alcohol-related deaths increased by 25% in 2020 and remained elevated in 2021.
LGBTQ+ People Are More Likely to Experience a Mental Health Condition
Minority Health Month fact: Lesbian, gay, bisexual, and transgender adults are more likely to experience a mental health condition than cisgender, heterosexual adults.
From Misdiagnosis to Building a Support System: Royce Thomas' Experience Living With Psoriasis
When a new “rash” appears on the skin, many people may not associate it with psoriasis.
IWBI Launches Global Network of Advisors to Advance Human Health and Equity in Cities
The International WELL Building Institute (IWBI) today announced the launch of its inaugural WELL City Advisory, which will explore ways to support local governments worldwide in demonstrating leadership on advancing health and well-being across their buildings, organizations and communities.
Opinion: The Road to Ending Visceral Leishmaniasis
If left untreated, VL kills 95% of its victims. Though progress has been made, we still have a way to go and, as we look to the next decade, eliminating VL will continue to be a priority for Gilead Sciences.
SC Johnson Chairman and CEO Welcomes Tanzanian President Hassan, Reaffirms Commitment to Helping Eradicate Malaria
SC Johnson Chairman and CEO Fisk Johnson welcomed Her Excellency Samia Suluhu Hassan, President of the United Republic of Tanzania, to Racine to discuss their shared commitment to eradicating malaria.